According to the investigation data of renal medicine, about 40% of the patients with nephrotic syndrome receive relatively good therapeutic effect after hormone therapy every year, although there is also recurrence after that. But the real life span has been extended.
Of the remaining 60% patients, once the body's urine protein is out of control, kidney damage is characterized by creatinine elevation, and 3/10 of these patients develop renal failure within a decade. Uremia.
In patients with nephropathy, the levels of IgG immunoglobulin and alpha globulin were found to be higher than normal. These two indicators are also the most difficult to control in the treatment of renal syndromes, so they are in the first place!
Kidney damage occurs in patients with kidney disease and is associated with high blood pressure, a pathological type that is likely to develop into renal failure, uremia. For patients with kidney disease, your doctor may not have prescribed a protein lowering drug (such as hormones). You may not have been prescribed creatinine lowering drugs, but blood pressure medications have been taken or are being taken. Antihypertensive drugs usually use sartan or priapril. The reasonable control standard for blood pressure was 90 / 130 mm Hg.
When patients develop symptoms of creatinine height and reduced renal function, the difficulty of treatment increases sharply. For example, crescene nephropathy, membranous proliferative nephropathy, is likely to have kidney failure in the early stages of the disease.
With the age of patients with kidney disease, the treatment of renal syndrome will become more and more difficult. In general, the older the age, the body's antioxidant capacity will be weakened, and the immune system will become worse. It's harder for the kidneys to get back to work, especially for people over 79 years of age.
Beijing In China